- Home
- GPCR vs DRH Comparison
GPCR vs DRH Comparison
Compare GPCR & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- DRH
- Stock Information
- Founded
- GPCR 2016
- DRH 2004
- Country
- GPCR United States
- DRH United States
- Employees
- GPCR N/A
- DRH N/A
- Industry
- GPCR
- DRH Real Estate Investment Trusts
- Sector
- GPCR
- DRH Real Estate
- Exchange
- GPCR Nasdaq
- DRH Nasdaq
- Market Cap
- GPCR 1.6B
- DRH 1.8B
- IPO Year
- GPCR 2023
- DRH 2005
- Fundamental
- Price
- GPCR $23.77
- DRH $8.22
- Analyst Decision
- GPCR Strong Buy
- DRH Hold
- Analyst Count
- GPCR 7
- DRH 5
- Target Price
- GPCR $81.29
- DRH $10.25
- AVG Volume (30 Days)
- GPCR 752.3K
- DRH 1.4M
- Earning Date
- GPCR 03-07-2025
- DRH 02-27-2025
- Dividend Yield
- GPCR N/A
- DRH 3.89%
- EPS Growth
- GPCR N/A
- DRH N/A
- EPS
- GPCR N/A
- DRH 0.29
- Revenue
- GPCR N/A
- DRH $1,114,379,000.00
- Revenue This Year
- GPCR N/A
- DRH N/A
- Revenue Next Year
- GPCR N/A
- DRH $2.73
- P/E Ratio
- GPCR N/A
- DRH $28.70
- Revenue Growth
- GPCR N/A
- DRH 4.50
- 52 Week Low
- GPCR $22.33
- DRH $7.74
- 52 Week High
- GPCR $62.74
- DRH $10.00
- Technical
- Relative Strength Index (RSI)
- GPCR 37.89
- DRH 37.37
- Support Level
- GPCR $22.33
- DRH $8.36
- Resistance Level
- GPCR $25.17
- DRH $8.78
- Average True Range (ATR)
- GPCR 1.73
- DRH 0.19
- MACD
- GPCR -0.37
- DRH -0.00
- Stochastic Oscillator
- GPCR 15.94
- DRH 16.67
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About DRH Diamondrock Hospitality Company
Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transient, business transient, and group customers.